Utilization and tolerance of beta-blockers among patients with AL amyloidosis
Article 2021 en
Authors
ΑB
Αlexandros Briasoulis
ΚS
Κimon Stamatelopoulos
ΙP
Ιoannis Petropoulos
Abstract
1 min read
Although some patients with CA may have indications for treatment with BB, their use is uncommon and those with more advanced disease tolerate BB poorly. Intolerance to BB in patients with cardiac AL is an indicator of poorer outcome.
Ashutosh Wechalekar, Efstathios Kastritis, Giampaolo Merlini, Philip N. Hawkins, Meletios A Dimopoulos, Julian D. Gillmore, Simon Gibbs, Giovanni Palladini
Discussion(0)
No comments yet. Be the first to comment.